Found: 96
Select item for more details and to access through your institution.
Immune therapeutic targeting of glioma cancer stem cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1023, doi. 10.1007/s00262-008-0618-y
- By:
- Publication type:
- Article
Topotecan enhances immune clearance of gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 2, p. 259, doi. 10.1007/s00262-008-0550-1
- By:
- Publication type:
- Article
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 123, doi. 10.1007/s00262-007-0336-x
- By:
- Publication type:
- Article
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Correction notice
Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 10, p. 823, doi. 10.3390/cells13100823
- By:
- Publication type:
- Article
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 8, p. 2032, doi. 10.3390/cells10082032
- By:
- Publication type:
- Article
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.907605
- By:
- Publication type:
- Article
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36430-2
- By:
- Publication type:
- Article
The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies.
- Published in:
- Surgical Neurology International, 2011, v. 2, n. 2, p. 1, doi. 10.4103/2152-7806.89886
- By:
- Publication type:
- Article
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03631-z
- By:
- Publication type:
- Article
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 617, p. 1, doi. 10.1126/scitranslmed.abe6201
- By:
- Publication type:
- Article
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 24, p. 13382, doi. 10.3390/ijms222413382
- By:
- Publication type:
- Article
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Blood–brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 151, n. 1, p. 65, doi. 10.1007/s11060-020-03425-8
- By:
- Publication type:
- Article
Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 429, doi. 10.1007/s11060-019-03311-y
- By:
- Publication type:
- Article
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 499, doi. 10.1007/s11060-019-03121-2
- By:
- Publication type:
- Article
Rethinking medulloblastoma from a targeted therapeutics perspective.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 3, p. 713, doi. 10.1007/s11060-018-2917-2
- By:
- Publication type:
- Article
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 2, p. 469, doi. 10.1007/s11060-018-2891-8
- By:
- Publication type:
- Article
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 1, p. 33, doi. 10.1007/s11060-017-2622-6
- By:
- Publication type:
- Article
The role of STAT3 in tumor-mediated immune suppression.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 3, p. 385, doi. 10.1007/s11060-015-1731-3
- By:
- Publication type:
- Article
Imatinib Mesylate Inhibits Platelet-Derived Growth Factor Receptor Phosphorylation of Melanoma Cells But Does Not Affect Tumorigenicity In Vivo.
- Published in:
- Journal of Investigative Dermatology, 2004, v. 122, n. 2, p. 400, doi. 10.1046/j.0022-202X.2004.22231.x
- By:
- Publication type:
- Article
Correction: Detecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv137
- By:
- Publication type:
- Article
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv137
- By:
- Publication type:
- Article
Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju162
- By:
- Publication type:
- Article
Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08271-x
- By:
- Publication type:
- Article
FGL2 promotes tumor progression in the CNS by suppressing CD103<sup>+</sup> dendritic cell differentiation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-08271-x
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Brain Metastases.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 6, p. 1, doi. 10.1007/s11912-017-0596-3
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors in Gliomas.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 4, p. 1, doi. 10.1007/s11912-017-0586-5
- By:
- Publication type:
- Article
Identification of metabolites in plasma for predicting survival in glioblastoma.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 8, p. 1078, doi. 10.1002/mc.22815
- By:
- Publication type:
- Article
Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 1, p. 137, doi. 10.1002/mc.22739
- By:
- Publication type:
- Article
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01680-0
- By:
- Publication type:
- Article
Hypoxia Potentiates Glioma-Mediated Immunosuppression.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016195
- By:
- Publication type:
- Article
Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005947
- By:
- Publication type:
- Article
Innate immune functions of microglia isolated from human glioma patients.
- Published in:
- Journal of Translational Medicine, 2006, v. 4, p. 15, doi. 10.1186/1479-5876-4-15
- By:
- Publication type:
- Article
The natural history of EGFR and EGFRvIII in glioblastoma patients.
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 38, doi. 10.1186/1479-5876-3-38
- By:
- Publication type:
- Article
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
- Published in:
- 2019
- By:
- Publication type:
- journal article
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad124
- By:
- Publication type:
- Article
Response of treatment-naive brain metastases to stereotactic radiosurgery.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47998-8
- By:
- Publication type:
- Article
EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma.
- Published in:
- Brain Pathology, 2009, v. 19, n. 4, p. 713, doi. 10.1111/j.1750-3639.2009.00318.x
- By:
- Publication type:
- Article
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 983, doi. 10.1007/s00262-013-1405-y
- By:
- Publication type:
- Article
Artificial intelligence in the radiomic analysis of glioblastomas: A review, taxonomy, and perspective.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.924245
- By:
- Publication type:
- Article
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682129
- By:
- Publication type:
- Article
Antigen-presenting B cells promote TCF-<sup>1+</sup> PD1<sup>-</sup> stem-like CD<sup>8+</sup> T-cell proliferation in glioblastoma.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2023.1295218
- By:
- Publication type:
- Article
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 3, p. 261, doi. 10.1215/15228517-2006-008
- By:
- Publication type:
- Article
Mechanisms of action of rapamycin in gliomas.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 1, p. 1, doi. 10.1215/S1152851704000420
- By:
- Publication type:
- Article
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1753, doi. 10.3390/cancers16091753
- By:
- Publication type:
- Article